Company Monitoring Page for Biomarin

latest headlines for company on cafepharma

Why BioMarin's Shares Tumbled 11% in June
Motley Fool
Sun, 07/10/16 - 12:09 pm
Tags:
Biomarin, M&A, Duchenne Muscular Dystrophy, Sanofi, drisapersen, Kyndrisa
BioMarin Pharmaceutical shares rise after possible takeover from Roche
CNBC
Thu, 07/7/16 - 04:02 pm
Tags:
Biomarin, M&A, Roche
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
Tags:
biotech, Acadia, AstraZeneca, Allergan, Biogen, Teva Pharmaceutical, Biomarin, Incyte, Ironwood, Medivation, Pfizer, Relypsa, Synergy Pharmaceuticals, M&A
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
Tags:
biotech, M&A, Alder Biopharmaceuticals, Biomarin, Coherus Biosciences, Intercept Pharma, Ultragenyx, Seattle Genetics, Adamas Pharmaceuticals, Alexion, Clovis Oncology, Corbus Pharmaceuticals, Incyte, Prothena, Puma Biotechnology, Tesaro, Versartis
BioMarin climbs on rumors it may be Sanofi's Medivation backup
Fierce Pharma
Fri, 06/17/16 - 09:38 pm
Tags:
Biomarin, Sanofi, Medivation, M&A
Biotech: Is the Rally Real?
Barron's
Thu, 06/2/16 - 04:01 pm
Tags:
biotech, Prothena, Biomarin, Vertex Pharmaceuticals, Incyte, Celgene
Why BioMarin’s Bad News is Great for Sarepta
Barron's
Wed, 06/1/16 - 09:43 pm
Tags:
Biomarin, Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen, drisapersen
BioMarin to Stop Developing its Duchenne Muscle Disease Drug
Bloomberg
Tue, 05/31/16 - 09:56 pm
Tags:
Biomarin, Duchenne Muscular Dystrophy, Kyndrisa
3 Biotech Stocks Buoyed By Potential Blockbuster Drugs
Investors.com
Sat, 05/7/16 - 01:13 pm
Tags:
JCAR015, Juno Therapeutics, Kyndrisa, Biomarin, Intercept Pharma, Ocaliva
BioMarin announces 'encouraging' early-stage hemophilia therapy data
Marketwatch
Wed, 04/20/16 - 09:37 am
Tags:
Biomarin, hemophilia, BMN 270
BioMarin drug for genetic disorder succeeds in late-stage study
Yahoo/Reuters
Mon, 03/21/16 - 09:01 am
Tags:
Biomarin, clinical trials, pegvaliase
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
Tags:
FDA, Rayaldee, OPKO Health, Nuplazid, Acadia, abaloparatide, Radius Health, pegvaliase, Biomarin, ALD403, Alder Biopharmaceuticals
Sanofi scouts for rare disease buyouts as Shire bears down on the field
Fierce Biotech
Tue, 03/1/16 - 09:37 am
Tags:
Sanofi, Shire, M&A, R&D, Biomarin, Ionis Pharmaceuticals, Ultragenyx
Why the FDA shouldn’t bow to parental pressure over Duchenne drug
Stat
Tue, 01/26/16 - 09:17 pm
Tags:
FDA, Duchenne Muscular Dystrophy, drug approvals, Biomarin, Sarepta Therapeutics
BioMarin Fails to Win Approval for Drug to Treat Deadly Duchenne
Bloomberg
Thu, 01/14/16 - 10:07 am
Tags:
Biomarin, FDA, Duchenne Muscular Dystrophy, Kyndrisa, drisapersen
4 Top FDA Decisions Expected in Q1
24/7 Wall St
Mon, 01/4/16 - 10:05 am
Tags:
FDA, Zafgen, beloranib, Biomarin, Peg-Pal, PB272, Puma Biotechnology, Aquinox, AQX-1125
What Does 2016 Hold for Biotech Stocks?
Motley Fool
Sun, 01/3/16 - 10:27 pm
Tags:
biotech, Gilead Sciences, Celgene, Amgen, Regeneron, Sanofi, Biomarin, Sarepta Th
How Gilead Sciences M&A Can Pan Out Next Year
Bidness, ETC
Tue, 12/29/15 - 09:36 am
Tags:
Gilead Sciences, M&A, Vertex Pharmaceuticals, Incyte, Biomarin, Regeneron
BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisa™ (drisapersen) New Drug Application by the PDUFA Date
Yahoo
Fri, 12/18/15 - 09:07 am
Tags:
Biomarin, FDA, drisapersen, Kyndrisa, Duchenne Muscular Dystrophy
FDA Committee Raises Concerns about Kyndrisa’s Efficacy, Safety
Yahoo/Market Realist
Fri, 12/11/15 - 10:27 pm
Tags:
FDA, Kyndrisa, Duchenne Muscular Dystrophy, Biomarin, drisapersen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.